KRAS and central nervous system cancer: Noor et al. suggested that in a KRAS-driven glioma mouse model, the autophagy inhibition considerably diminished the growth of glioma and oncogenic progression by genetically suppressing ULK1 or Atg7 and Atg13, showing that autophagy is vital during the early phase in glioma pathogenesis [58].